Company ProfilePremium

Alticast Corporation

Company Profile Analysis

Ticker: 085810.KQ주식회사 알티캐스트

ESOMAR 23 Corporate BadgeISO Certifications Badge
Alticast Corporation - Company showcase

Year Founded & Workforce

1999

39 Employees

Alticast Corporation logo

Alticast Corporation Employee Contacts

3 verified contactsNames, job titles, seniority and locations

View Employee Contacts

Alticast Corporation Overview

Headquarters address note:

  • S&P lists "Park Building, Seoul 06655" (postal code 06655 is in Seocho-gu).

  • Jasoseol (public data aggregator) lists 4F, 12 Teheran-ro 7-gil, Gangnam-gu, Seoul (Yeoksam-dong, Heoba-Heoba Building).

The discrepancy is unresolved; the current registered address should be confirmed against the latest DART filing.

Trend: A verified three-year trend is not publicly disclosed in sources reviewed.

Group headcount: This figure (including Daehyun Gigeon and Aptamer Sciences) is not disclosed in sources reviewed.

Alticast is no longer the pure-play broadcast software house that listed on KOSDAQ in 2013. That franchise covered middleware, conditional access and DRM for Korean IPTV and cable operators. It was carved out and sold to KT in 2021.

After three years of shrinking software revenue and heavy losses under Humax ownership, control passed in December 2024 to Beno T&R, an investment-driven KOSDAQ group. Alticast has since been reshaped into a small holding-style vehicle with three parts:

Legacy software and platform business: mobility SaaS (RAiDEA), connected-vehicle IoT, cloud UI, QA services and a blockchain payments subsidiary.

HVAC and fire-protection contractor: Daehyun Gigeon, acquired in April 2025, which now drives most revenue.

Influential stake in Aptamer Sciences: a KOSDAQ bio/CRO company that is pivoting into US premium pet food.

The equity story rests on Daehyun Gigeon's cash generation and option value in the bio/pet-food stake. Against that sit thin margins, recurring dilution, related-party complexity and KOSDAQ listing-maintenance risk.


Company's own description

Recent company statements (March and April 2026 press releases via Asia Economy) still introduce Alticast as a digital broadcasting software specialist. They describe the current portfolio in three pillars:

Cash generation: Daehyun Gigeon (HVAC/fire-protection) is described as the stable cash-generating core.

Growth: Aptamer Sciences is positioned as the growth engine, through drug-delivery technology, CRO services (via ISS) and US pet food (via Choolip).

New business: Subsidiary Altiplatform (알티플랫폼) develops blockchain-based enterprise payment and promotion systems for B2B customers.

Management targets North American expansion and fixed-cost reduction in 2026. Its stated ambition is to become a "quality company" within two to three years.

The S&P business description, last updated October 2026, still reflects the pre-2025 software catalogue. It says Alticast develops mobility services and device platforms, citing RAiDEA, OTOPLUG and AltiCloud UI.

Independent characterisation

Alticast is best understood as a micro-cap holding company with an operating construction-services subsidiary bolted onto a residual software business. The evidence is in the margins:

Gross margin collapse: Consolidated gross margin fell from 94.6% in FY2021 (pure software) to 25.0% in FY2025, and 17.4% on a trailing twelve-month basis to June 2026 (S&P).

What this means: The mix is now dominated by low-margin contracting revenue.

Daehyun Gigeon's scale: Management says Daehyun Gigeon's standalone revenue is in the high-KRW-60 bn range per year. That is larger than the entire consolidated group before the acquisition.

Business model and revenue model

Business lineRevenue modelValue-chain positionCustomer types
HVAC and fire-protection installation (Daehyun Gigeon)Project/contract revenue, recognised over construction progress (inferred from industry practice; not confirmed in sources)Specialty subcontractor to general contractorsTier-1 Korean construction companies (company statement)
Mobility SaaS (RAiDEA), IoT (OTOPLUG), cloud UILicence, platform fees, SI/customisation (historical disclosures)Software vendor / platform providerMobility operators, car-sharing/rental firms, telcos, STB operators
Platform QA / verification servicesService feesOutsourced QA providerTelcos and platform operators (e.g., KT contract, see Section 14)
Blockchain payments / promotions (Altiplatform)—Early-stage B2B platformEnterprises (B2B)
Bio, CRO and pet food (Aptamer Sciences, via stake)Diagnostics, CRO analytical services, consumer productsDrug-delivery R&D, bioanalytical CRO, branded pet foodPharma/biotech clients; US pet retail (Amazon, Costco)

Revenue mix: A product vs. service vs. subscription vs. licensing split is not publicly disclosed in sources reviewed.

End-markets: These are Korean commercial and residential construction (MEP), Korean mobility and telecom software, and drug development services and US pet consumables (via Aptamer).

Strategy

Stated strategy (paraphrased from company releases, March–April 2026)

  1. Financial normalisation.

    • Eliminate the accumulated deficit via the 5-to-1 capital reduction and transfer of capital surplus to retained earnings.

    • Shed the "penny stock" image.

    • Comply with tightened KOSDAQ listing-maintenance rules.

    • Create legal capacity for future dividends or treasury-share cancellation.

  2. Cash-flow anchor. Use Daehyun Gigeon's backlog with tier-1 contractors as the earnings base.

  3. Growth via Aptamer Sciences. Drug-delivery R&D, CRO services and the Choolip pet-food platform, with US retail expansion in 2026.

  4. Blockchain B2B. Altiplatform's enterprise payment and promotion systems.

  5. Cost and geography. North American expansion and fixed-cost reduction expected to take effect in 2026.

  6. Medium-term ambition. Become a high-quality company within two to three years. No quantified targets were given.

Initiatives in the last 24 months

DateInitiativeTypeTargets / status
Dec 2024–Jan 2025Beno T&R recapitalisation (rights issue plus perpetual CB; about KRW 40 bn planned including FIs)Capital raiseBeno portion completed 24 Dec 2024
Jan 2025Blockchain game platform; robotics/AI cooperation with Human in Motion Robotics (Beno affiliate; XoMotion-R exoskeleton)New business / partnershipNo subsequent results disclosed
Apr 2025Daehyun Gigeon acquisitionM&A / diversificationCompleted
Sep–Oct 2025Aptamer Sciences control investmentM&ACompleted 27 Oct 2025
Sep 2025Third-party share issue to Vision2Capital raiseCompleted 30 Sep 2025
Mar–Apr 20265-to-1 capital reduction; deficit eliminationCapital restructuringEffective 8 Apr 2026
Mar 2026Choolip acquisition via Aptamer (USD 11.4 m)M&A (subsidiary level)Announced 25 Mar 2026
2,026Altiplatform B2B blockchain commercialisationNew businessPending

Not disclosed in sources reviewed:

  • Medium-term financial targets / guidance: none publicly quantified.

  • ESG / sustainability commitments: none disclosed.

Products & Services

Software and platforms (parent)

ProductDescriptionKey capabilitiesTarget customerLaunch / latest versionPricing model
RAiDEA (mobility service platform)All-in-one mobility platformStation-based and free-floating car sharing, car hailing, rental automation, micro-mobility; round-trip, one-way and free-floating modes; B2C, B2B and P2P (S&P; Aju 2021)Car-sharing, rental and mobility operators. Reference deployments: Humax Mobility Carplat Biz and WAY (2021)In commercial use by 2021; latest version not disclosed—
RAiDEA Smart ParkingSmart-parking platformIntroduction, operation, connection and expansion of smart-parking services (S&P)Parking operators——
OTOPLUGCloud-based vehicle IoT platformConnection services with vehicles (S&P)Fleet and mobility operators, OEM partners——
AltiCloud UICloud-rendered user interfaceRuns the UI in the cloud and delivers a lightweight presentation layer to STBs and mobile clients (S&P)Pay-TV operators, device makers——
Platform QA / verification servicesQuality-verification services for mobility and other platformsOutsourced testingTelcos and platform operators—Service fees
In-car payment / connected-car commerceMobility payment services (MyDailyByte summary)In-car paymentsMobility operators——

Blockchain (Altiplatform)

OfferingDescriptionStatus
Enterprise blockchain payment solutionBlockchain-based corporate payment systemCommercialisation targeted in B2B. Management expected visible results soon as of March 2026.
Promotion systemBlockchain-based promotionsAs above
Blockchain game platformAnnounced as a strategic direction after the Beno T&R investment (Jan 2025)Status not disclosed

HVAC and fire protection (Daehyun Gigeon)

OfferingDescriptionCustomers
HVAC (air-conditioning and ventilation) installationMechanical equipment installation as a specialty contractorTier-1 Korean general contractors
Fire-protection systemsFire-protection equipment installationAs above

Order backlog: Management states the backlog is rising. A specific figure is not disclosed.

Bio, CRO and pet food (Aptamer Sciences, via stake)

Product / serviceDescriptionStatus
Aptamer drug-delivery platformsAlloMAp (allosteric modulator aptamer) and BiFAp (bi-functional aptamer) platforms, including BBB-shuttle and chimeric aptamer approachesResearch / preclinical; lead pipeline AST-201 in clinical testing per the company (Money Today, Jul 2025)
AptoDetect-LungBlood-based lung-cancer early-detection kit using a seven-protein aptamer panelKorean MFDS Class III approval, September 2017
Bioanalytical CRO (ISS)Preclinical and clinical sample analysisMerged via small-scale merger effective 19 Aug 2024
Research reagents and samples distributionDistribution business expanded to secure revenue baseOngoing
Squeeze Vita Stick (Choolip)Creamy paste pet treat with 30+ vitamins and nutrients, positioned around organ-specific nutritionSold on Amazon and at Costco
Berry Good Milk (Choolip)Vitamin-fortified, lactose-free pet milkRanked first in the cat new-product showcase at SuperZoo 2024

ISS background. International Scientific Standard was founded in 2008 as a joint venture of Battelle Memorial Institute and Yuyu Pharma. Its purchase price was reported as within KRW 2 bn.

Choolip scale and plans:

  • 2025 Amazon sales of 94,789 units and about USD 2.83 m in orders (Money Today, Mar 2026).

  • Planned 2026 retail expansion targets reported by Asia Economy: Walmart (500–900 stores), TJ Maxx (5,000), Petco (1,300) and Target (500).

Name change flag. The IRGO investor-relations portal lists Aptamer Sciences' IR room under the name "Choolip & Science" (츌립앤사이언스). This suggests a 2026 corporate rename, but it is not independently confirmed.

Divested legacy products (for reference)

The following were sold with Altimedia to KT in 2021 and are no longer Alticast products:

  • Digital broadcast middleware

  • CAS/DRM

  • Server solutions

  • UI/UX

  • Applications

  • Browsers

  • HTML5 smart package

  • RDK-based solutions

  • Software CAS

Financial Narrative

Source for all tables: S&P Global Market Intelligence via StockAnalysis.com (annual data, fiscal years ending 31 December; KRW millions; per-share data adjusted for the April 2026 1-for-5 reverse split).

Income statement

Notes:

  • Company-reported FY2025 operating profit is KRW 3.2 bn vs. S&P's KRW 1.909 bn.

  • FY2022 also includes a KRW 3.70 bn goodwill impairment and KRW 4.03 bn loss on investment sales.

  • FY2023 includes KRW 7.21 bn loss on investment sales.

  • FY2024 includes KRW 4.51 bn loss on investment sales.

Dividend flag: One aggregator (Eulerpool) displays a dividend yield of about 46.7%. S&P and the cash-flow statement record no dividends paid. The aggregator figure is treated as a data error.

Margins

Revenue CAGR:

Both CAGRs are acquisition-driven and not organic. Organic revenue in the legacy software business fell about 84% between FY2021 and FY2024.

Balance sheet

Notes:

Equity series: Total equity is shown as total assets minus total liabilities. S&P's "total common equity" line is internally inconsistent for FY2022–FY2023 and is not used.

Trading securities: FY2025 cash plus short-term investments includes KRW 12.09 bn of trading securities.

30 June 2026 balance sheet (TTM column): - Total assets KRW 80.89 bn

  • Cash and short-term investments KRW 10.79 bn

  • Total debt KRW 13.55 bn, giving net debt of KRW 2.75 bn

  • Equity KRW 50.55 bn

  • Common stock reduced to KRW 7.15 bn and retained earnings turned positive at KRW 6.55 bn, consistent with the capital reduction and reserve transfer

Cash flow

TTM to June 2026: Operating cash flow was KRW –6.69 bn and free cash flow KRW –6.79 bn. Working capital absorbed KRW 11.6 bn, consistent with a growing construction receivables book.

Ratios

Net debt / EBITDA: This is meaningful only in years with positive EBITDA: FY2021 –2.58x and FY2025 –4.63x (both net cash).

TTM to June 2026: Net debt / EBITDA is about 2.0x on KRW 1.37 bn EBITDA.

Cash conversion cycle: Not computable from available data; inventory is immaterial, and payables were not reported before FY2025. Not publicly disclosed.

Receivable days: Calculated as accounts receivable ÷ revenue × 365, using S&P accounts receivable.

Trailing performance (TTM to 30 June 2026)

Derived from the change in TTM: Q2 2026 revenue was about KRW 5.2 bn higher than Q2 2025, while Q2 2026 operating income was about KRW 1.7 bn lower. This points to a weak, loss-making Q2 2026 despite the full-quarter Daehyun contribution.

Commentary on trends, inflections and drivers

  1. FY2021–FY2022 collapse.

    • The sale of the media business to KT (agreed April 2021, closed December 2021) removed the core revenue engine.

    • Revenue fell from KRW 36.3 bn to KRW 7.2 bn.

    • The remaining mobility/EV-charging ventures did not scale, as shown by the KRW 3.7 bn goodwill impairment in FY2022 and recurring discontinued-operations losses.

  2. FY2022–FY2024 cash burn and balance-sheet erosion.

    • Total equity fell from KRW 64.7 bn to KRW 30.0 bn by FY2023.

    • Repeated losses on investment disposals (KRW 4.0 bn, 7.2 bn, 4.5 bn) and equity-method losses (KRW 4.2 bn, 6.3 bn) indicate a portfolio of non-core financial investments that destroyed value.

    • The FY2023 current ratio dipped below 1.0x.

  3. FY2024 recapitalisation.

    • The Beno T&R-led rights issue and perpetual CB brought in about KRW 25.8 bn of FY2024 financing inflows (KRW 10.5 bn common stock plus KRW 15.3 bn other financing).

    • Cash was restored to KRW 23.3 bn and debt cut to KRW 3.8 bn.

  4. FY2025 inflection.

    • The Daehyun Gigeon acquisition drove revenue up about 9x and returned the group to a small operating profit.

    • The trade-off is a structurally lower margin profile: 25% gross and 3.6–6% operating (S&P vs. company).

    • Cash outflow for acquisitions (KRW 16.2 bn) consumed most of the 2024 capital raise.

  5. 2026 deterioration.

    • TTM operating income turned negative by June 2026.

    • Net debt re-emerged at KRW 2.75 bn, and short-term debt rose to KRW 10.1 bn.

    • Gross margin compressed to 17.4%. The recovery narrative has not yet translated into sustained earnings or cash generation.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Operating Unit Details

Operating unitLegal entityContentsOwnershipConsolidation status

Software and platforms

Alticast Corporation (parent)

RAiDEA mobility and parking SaaS, OTOPLUG vehicle IoT, AltiCloud UI, platform QA/verification services

100%

Parent

Blockchain payments

Altiplatform (알티플랫폼)

Blockchain-based enterprise payment and promotion systems

Described as a subsidiary; % not disclosed

Not confirmed

HVAC and fire protection

Daehyun Gigeon (대현기건)

Mechanical HVAC and fire-protection installation; about 40-year operating history

Acquired April 2025; % not disclosed

Consolidated, inferred from the FY2025 revenue step-up and new goodwill/intangibles

Bio, CRO and pet food

Aptamer Sciences (압타머사이언스)

Aptamer-based drug delivery and diagnostics; bioanalytical CRO via merged ISS; Choolip US pet food

17.59% direct at 27 Oct 2025, plus related-party holdings (see note below)

Described by the company as a "subsidiary"; accounting treatment not confirmed. FY2025 shows KRW 1.85 bn of equity-method losses and KRW 3.2 bn minority interest, so both treatments are plausible for different stakes.

Revenue by Segment and Segment Margins & Growth (%)

MetricFY2023FY2024FY2025

Consolidated revenue (KRW Mn)

5,6585,68153,166

Consolidated operating income (KRW Mn)

-9,609-5,2401,909

Operating margin (%)

-169.81-92.253.59

Revenue YoY growth (%)

-21.900.40835.91

Income Statement and Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (KRW Mn)

36,2547,2455,6585,68153,166

Revenue growth (%)

-17.79-80.02-21.900.40835.91

Cost of revenue (KRW Mn)

1,96215943,26039,858

Gross profit (KRW Mn)

34,2927,0865,6542,42013,308

SG&A (KRW Mn)

27,74214,7788,5155,5848,338

Operating income — S&P (KRW Mn)

193-9,958-9,609-5,2401,909

EBITDA (KRW Mn)

3,837-8,730-8,737-4,3883,135

D&A (KRW Mn)

3,6431,2288718521,225

Interest expense (KRW Mn)

4171,1101,4001,598413

Equity-method income (KRW Mn)

00-4,200-6,281-1,848

Pre-tax income (KRW Mn)

3,170-16,389-20,037-15,827856

Income tax (KRW Mn)

2,38768459843

Discontinued operations (KRW Mn)

-5,694-1,740-6,3882,6120

Net income attributable to parent (KRW Mn)

-4,911-17,817-25,974-13,032-813

EPS basic, split-adjusted (KRW)

-860.71-3,081.95-4,492.87-2,196.38-78.44

EPS diluted, split-adjusted (KRW)

-860.71-3,081.95-4,492.87-2,196.38-78.44

Dividends per share (KRW; 0 = no payment recorded)

00000

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Gross margin (%)

94.5997.8199.9342.6025.03

Operating margin — S&P (%)

0.53-137.46-169.81-92.253.59

EBITDA margin (%)

10.58-120.50-154.42-77.245.90

Net margin (%)

-13.55-245.94-459.04-229.42-1.53

Calculation by Period

PeriodCalculationCAGR

FY2021–FY2025 (4-year)

(53,166 / 36,254)^(1/4) – 1

≈ 10.0%

FY2020–FY2025 (5-year)

Using FY2020 revenue of KRW 44.5 bn (Aju/DART)

≈ 3.6%

Balance Sheet and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Total assets (KRW Mn)

83,17669,96150,18644,79474,856

Cash and equivalents (KRW Mn)

23,2219891,30823,3186,997

Cash and short-term investments incl. trading securities (KRW Mn)

23,3201,0781,30823,31821,120

Short-term debt incl. current lease and current LTD (KRW Mn)

3,8082,02610,3013,4085,086

Long-term debt incl. long-term leases (KRW Mn)

9,5958,5066,5303441,533

Total debt (KRW Mn)

13,40210,53216,8313,7536,619

Net debt (KRW Mn; negative = net cash)

-9,9189,45415,524-19,565-14,501

Total shareholders' equity (KRW Mn)

64,74855,74630,01036,85054,011

Goodwill and other intangibles (KRW Mn)

11,0887,3283,74096,113

Long-term investments (KRW Mn)

33,69035,83527,47616,23725,806

Working capital (KRW Mn)

22,5505,850-1,49320,97120,611

Book value per share, split-adjusted (KRW)

11,452.608,452.503,962.283,816.504,129.22

Cash Flow

MetricFY2021FY2022FY2023FY2024FY2025

Operating cash flow (KRW Mn)

-3,211-8,833-3,770-3,836-2,155

Capital expenditure (KRW Mn, outflow negative)

-477-265-24-31-410

Free cash flow (KRW Mn)

-3,688-9,098-3,795-3,867-2,565

Cash acquisitions (KRW Mn)

8,997-1930-8-16,245

Divestitures (KRW Mn)

13,2390000

Common stock issued (KRW Mn)

00010,5395,999

Other financing incl. hybrid / perpetual CB (KRW Mn)

0864-1915,2516,900

Dividends paid (KRW Mn)

00000

Share buybacks (KRW Mn)

-1830000

Net change in cash (KRW Mn)

5,904-22,23231922,010-16,321

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2021FY2022FY2023FY2024FY2025

ROE (%)

1.17-27.21-46.93-47.520.03

ROA — S&P (%)

0.14-8.13-10.00-6.901.99

ROIC (%)

0.08-16.59-17.35-16.680.10

Current ratio (x)

4.252.450.873.952.13

Quick ratio (x)

3.911.560.393.621.54

Debt / equity (x)

0.210.190.560.100.12

Interest coverage, EBIT / interest (x)

0.46-8.97-6.86-3.284.63

Asset turnover (x)

0.430.100.090.120.89

Receivable days, derived (days)

3014917812447

Income Statement

MetricTTM Mar-2026TTM Jun-2026

Revenue (KRW Mn)

69,02674,269

Gross profit (KRW Mn)

14,43912,900

Operating income — S&P (KRW Mn)

1,378-289

Net income attributable (KRW Mn)

not shown

-5,404

Revenue by Region

MetricFY2023FY2024FY2025

Total revenue (KRW Mn)

5,6585,68153,166

Region Overview

RegionExposureEvidenceDirection

South Korea

Near-total: construction services (Daehyun Gigeon), domestic mobility/telecom software and QA (e.g., KT contract)

Business composition

Growing (acquisition-driven)

North America

Emerging: management targets North American expansion in 2026; Aptamer's Choolip operates from California and sells via Amazon/Costco

Asia Economy, Mar 2026; Money Today, Mar 2026

New. It reaches Alticast only if Aptamer is consolidated, or indirectly via equity value.

Vietnam, Netherlands, Turkey (historical)

Legacy media-software footprint (Viettel, Türk Telekom clients)

Aju, Dec 2021

Exited with the Altimedia sale to KT in 2021

Capital Markets Data (KRW) and Market Valuation

MetricFY2021FY2022FY2023FY2024FY2025

Year-end close, split-adjusted (KRW)

12,1258,8005,6105,9802,935

Year-end market capitalisation (KRW Mn)

70,09750,87532,43336,24135,235

Year-end enterprise value (KRW Mn)

65,99857,74352,18754,1146,404

Year-end P/S (x)

1.937.025.736.380.66

Year-end P/B (x)

1.080.911.080.980.65

Year-end EV/Sales (x)

1.827.979.229.530.12

Shares outstanding, split-adjusted (M)

5.785.785.789.6612.30

Change by Period

PeriodChangeBasis

1-year

–54.8%

S&P 52-week change at 9 Sep 2026

Since FY2023 close (≈3 years)

–75.0%

vs. KRW 5,610

Since FY2021 close (≈5 years)

–88.4%

vs. KRW 12,125

Valuation Multiples

MultipleAlticast (Sep–Oct 2026)

P/E

Not meaningful (TTM loss)

EV/EBITDA

Not meaningful TTM (EBITDA KRW 1.37 bn implies about 19x on EV KRW 26.3 bn)

EV/Sales

0.35x

P/B

0.40–0.42x

P/TBV

0.51–0.52x

P/S

0.28x

Capital Markets

ItemStatus

Analyst consensus

None (S&P: no analysts, no price target)

Dividend history

No dividends recorded FY2021–FY2025 (S&P). Policy: none paid; capital reduction intended to enable future dividends or treasury-share cancellation (company).

Buyback authorisations

None disclosed. Last recorded repurchase KRW 183 m in FY2021; treasury share cancellation of 157,000 shares reported (undated).

Credit ratings (Moody's / S&P / Fitch)

Not rated

Debt maturity profile

Not disclosed. At June 2026: short-term debt KRW 10.1 bn, current portion of long-term debt KRW 1.76 bn, long-term debt KRW 1.04 bn, leases KRW 0.64 bn (S&P). About 87% of debt is due within 12 months.

Analyst Conclusions

Management guidance and consensus

Management guidance: No quantified guidance. Management expects North American expansion and lower fixed costs to improve stability in 2026. It targets "quality company" status within two to three years (Asia Economy, Mar–Apr 2026).

Consensus: No sell-side coverage; consensus not available.

Bull case

  1. Earnings floor. Daehyun Gigeon's high-KRW-60 bn annual revenue and growing backlog give a durable floor. A full-year FY2026 consolidation could lift revenue toward the KRW 70–80 bn TTM run-rate (S&P TTM KRW 74.3 bn).

  2. Deep discount to assets. At about 0.4x book and 0.5x tangible book, the market assigns little value to the Aptamer stake, the KRW 23 bn of long-term investments or the KRW 7.8 bn of land and buildings.

  3. Financial clean-up done. Deficit elimination and the reverse split remove technical overhangs. Any return to profit could support first-ever distributions.

Bear case

  1. Earnings quality is poor and deteriorating. TTM operating income turned negative, gross margin fell to 17.4%, and free cash flow has been negative for five straight years.

  2. Governance and control risk dominates. Alticast sits under Beno T&R, whose own control sale is delayed. Related parties co-invest alongside the company, and the shareholder base has absorbed about 75% (FY2025) and about 50% (TTM) dilution.

  3. Listing-maintenance pressure is acute. Market cap of about KRW 19–20 bn is at or below the new KOSDAQ minimum and well below the KRW 30 bn bar from January 2027. This creates pressure for further equity issuance or corporate actions that may not favour minorities.

Catalysts and monitorables (next 12 months)

MonitorableWhat to watch
Beno T&R change of controlCompletion of the Acro New Technology Fund No. 241 transaction and any knock-on change in Alticast's board or strategy
KOSDAQ market capSustained trading above KRW 20 bn, and progress toward the KRW 30 bn requirement before January 2027
Q3 2026 results (due about mid-November 2026)Whether operating profit recovers; Daehyun margins; receivables trend
Aptamer Sciences / ChoolipChoolip closing; US retail roll-out (Walmart, Petco, Target, TJ Maxx); Aptamer's consolidation treatment and share price
Capital raisingAny new third-party allotments, CBs or perpetual instruments
AltiplatformFirst disclosed B2B blockchain contracts
Shareholder returnsAny dividend or treasury-share cancellation now that the deficit is cleared

Analyst verdict

Alticast Corporation today bears little resemblance to the company that listed on KOSDAQ in December 2013. The broadcast-middleware franchise that once generated KRW 65 bn of revenue and double-digit margins was sold to KT in 2021 for about KRW 11 bn. Three years of losses followed: cumulative net losses of roughly KRW 57 bn between FY2022 and FY2024.

The December 2024 entry of Beno T&R, and the 2025 acquisitions of Daehyun Gigeon and a controlling position in Aptamer Sciences, have produced a headline turnaround. Revenue rose ninefold to KRW 53.2 bn in FY2025, and operating profit of KRW 1.9–3.2 bn was the first in four years. A 5-to-1 capital reduction has cleaned up the accumulated deficit.

Underneath, the picture is less convincing:

Acquired growth: The growth is acquired, not organic, and comes at contractor-level margins.

Relapse: TTM operating income was already back in the red by June 2026, and free cash flow has been negative for five consecutive years.

Funding by dilution: Growth has been funded through repeated dilutive placements.

Complex governance: The structure involves a listed parent whose own control is changing hands, related parties investing alongside the company, and limited governance disclosure. This warrants a substantial discount.

The valuation reflects that scepticism. At 0.4x book and about 0.3x sales, the shares price in either continued value leakage or a high probability of further dilution. The most pressing near-term issue is mechanical rather than fundamental. Market capitalisation of about KRW 19–20 bn sits at the new KOSDAQ minimum and well short of the KRW 30 bn bar that applies from January 2027. That raises the odds of further corporate actions whose terms may favour insiders.

Verdict: Alticast is a speculative special situation, not an investment-grade operating story. Deep-value investors could find asset backing attractive only with clear evidence of three things:

  1. Sustained positive operating cash flow at Daehyun Gigeon.

  2. A stable, completed change of control at Beno T&R.

  3. A credible plan to clear the 2027 listing threshold without further heavy dilution.

Until then, governance and listing risks outweigh the balance-sheet discount.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenure / background

Chung Wook-jae (정욱재)

CEO / Representative Director

Executive director and CFO at the 2013 IPO (eToday, Nov 2013); now CEO (S&P; Asia Economy, Mar 2026). Start date as CEO not disclosed.

Chung Jip-hoon (정집훈)

Co-Representative Director (per TheVC and Jasoseol)

CEO of Beno T&R; certified public accountant (Sidae, 2023); held 26.73% of Lamicus as of 2023

Kang Won-chul (강원철)

Former CEO

CEO at 2013 IPO

Seo Jung-kyu (서정규)

Former CEO

CEO during the Humax-era sale process; reported to have faced a breach-of-trust complaint

Major Shareholders

HolderStakeDate / basisSource

Beno T&R Co., Ltd.

Largest shareholder; % not disclosed in sources reviewed

Since Dec 2024

Asia Economy

Vision2 Co., Ltd. (비전2)

15.01% (9,124,086 pre-reduction shares)

30 Sep 2025

Digital Today

Insiders (aggregate)

2.38%

S&P, Sep 2026

S&P

Free float

3.71 m shares (~26.5% of 13.98 m)

S&P, Sep 2026

S&P

Treasury shares

Carried at KRW 3.12 bn (FY2025); TheVC headline reports cancellation of 157,000 common shares (date not stated)

—

S&P; TheVC

Governance Detail

StepDetailSource

Beno T&R's controller

Lamicus became Beno T&R's largest shareholder in March 2023 with 15.79%

Sidae

Lamicus ownership

Lamicus's largest shareholder is investor Park Hyung-jun (73.27%), described in press as an M&A specialist and referred to as "chairman". Not to be confused with the Busan politician of the same name.

Sidae, 2023

Related vehicle

Press reports link Park to J&J Investment, through which he acquired Beno T&R and JK Synapse

TheVC news index

Sale agreement (3 Jul 2026)

Lamicus and Chung Jip-hoon agreed to sell 4,782,496 Beno T&R shares (12.75%) to Acro New Technology Fund No. 241 at KRW 7,100/share (about KRW 33.96 bn)

Edaily; Chosun Biz

Accompanying placement

KRW 10 bn placement of 11,737,089 new Beno T&R shares at KRW 852

Edaily; Chosun Biz

Premium controversy

Press criticised the control premium (reported at about 600%) relative to the discounted new-share issue

Chosun Biz

Payment status

KRW 10 bn deposit paid. The KRW 23.96 bn balance was postponed from 27 Aug to 14 Sep 2026; a further Acro placement is scheduled for 23 Dec 2026.

Dealsite, Aug 2026

Completion

Not confirmed in sources reviewed as of 15 Oct 2026

—

Competitive Landscape

Competitors by Segment

SegmentNamed competitors / peersBasis

Media / platform software (residual)

KT Altimedia (Alticast's former media business), TVStorm (티비스톰), Birdland Software (버드랜드소프트웨어), ERmind (이알마인드), Castis (캐스트이즈, VOD/media delivery)

TheVC peer mapping; Wanted company profile

Mobility SaaS

Humax Mobility group (historical partner and potential competitor)

Aju, 2021

HVAC / fire-protection subcontracting

Specific competitors not identified in sources reviewed

Fragmented Korean specialty-contractor market

Bioanalytical CRO / aptamer therapeutics (Aptamer)

Specific competitors not identified in sources reviewed

—

US premium pet food (Choolip)

Specific competitors not identified in sources reviewed

—

Peer Comparison FY2025

MetricAlticast (FY2025)KT Altimedia

Revenue

KRW 53.2 bn

—

Revenue growth

+835.9%—

Operating margin

3.6% (S&P) / about 6.0% (company)

—

Employees

39–71

178 (TheVC, Jun 2026)

“—” = not publicly disclosed.

Company Snapshot

$37.4M

Revenue

39

Employees

1999

Founded

SWOT Analysis

Strengths

  • Revenue scale-up. Revenue rose from KRW 5.7 bn (FY2024) to KRW 53.2 bn (FY2025) after the Daehyun Gigeon acquisition (S&P).
  • Return to operating profit. FY2025 operating profit was KRW 1.9 bn (S&P) or KRW 3.2 bn (company), the first annual operating profit since FY2021.
  • Clean equity account. The accumulated deficit was eliminated: retained earnings went from KRW –53.2 bn (FY2025) to KRW +6.5 bn (June 2026) via the reserve transfer (S&P).
  • Low leverage. FY2025 debt/equity was 0.12x with net cash of KRW 14.5 bn (S&P).
  • Discount to book. The stock trades at about 0.40x P/B and 0.51x P/TBV (S&P, Sep 2026), so asset backing is high relative to the market value.
  • Liquid bio stake. The 17.59% direct stake in KOSDAQ-listed Aptamer Sciences (7,079,827 shares) can be monetised.

Weaknesses

  • Margin compression. Gross margin fell from 94.6% (FY2021) to 17.4% (TTM June 2026) as low-margin contracting dominates (S&P).
  • Persistent cash burn. Free cash flow was negative in each of the last five years (FY2021–FY2025) and TTM to June 2026: –KRW 6.8 bn (S&P).
  • Profitability relapse. The TTM operating result turned to a KRW 0.29 bn loss by June 2026 and TTM net loss was KRW 5.4 bn (S&P).
  • Value-destructive investments. Losses on investment sales totalled about KRW 15.7 bn over FY2022–FY2024, plus KRW 10.5 bn of equity-method losses in FY2023–FY2024 (S&P).
  • Thin governance disclosure. Board, compensation and segment data were not available in public sources reviewed.
  • Hollowed-out software franchise. The core broadcast IP and international base were sold to KT for only about KRW 11.3 bn (2021).

Opportunities

  • Contracting growth. Management reports a rising order backlog with tier-1 contractors at Daehyun Gigeon (Asia Economy, Mar 2026).
  • Pet-food upside via Aptamer. Choolip's 2025 Amazon orders were about USD 2.83 m, with planned entry into thousands of US retail doors.
  • Shareholder returns. The deficit clean-up legally enables future dividends or buybacks (company statement).
  • Blockchain B2B. Altiplatform commercialisation could add a higher-margin revenue stream (company statement; unproven).
  • Asset sales. Long-term investments of KRW 23.0 bn (June 2026) could be realised to fund growth or returns.
  • Robotics/AI. Cooperation with a robotics affiliate (Human in Motion Robotics; Health Canada-approved XoMotion-R) could create a software services line (speculative).

Threats

  • Listing maintenance. Market cap of KRW 19.2–19.6 bn sits below the KOSDAQ KRW 20 bn threshold, which rises to KRW 30 bn in January 2027 (Sidae; S&P).
  • Parent instability. Beno T&R's control sale is unconfirmed (balance deferred to 14 Sep 2026), and Beno itself traded below KRW 1,000 for 25 sessions (Dealsite).
  • Ongoing dilution. Shares rose 74.7% in FY2025 and 50.4% year-on-year to mid-2026 (S&P buyback/dilution yield).
  • Construction-cycle and counterparty risk. Receivables rose to KRW 18.2 bn at June 2026 from KRW 13.1 bn at FY2025 (S&P).
  • Related-party conflicts. Daehyun Gigeon (a subsidiary) and Lamicus (the controller's controller) co-invested in Aptamer, so minority-shareholder interests may diverge (Dealsite, Sep 2025).
  • Weak financial-health scores. Altman Z-Score is 1.79 and Piotroski F-Score 2 (S&P, Sep 2026).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Apr 2025Acquisition of Daehyun Gigeon completedTransforms revenue base; restores operating profit
Jul 2025Aptamer Sciences denied sale rumours and said it was reviewing strategic investment (before the Alticast deal)Context for the Alticast entry
Jul 2025Beno T&R (Alticast's parent) planned a KRW 30 bn raise from Hamil IB, drawing press doubts over the investor's capacityParent-level funding fragility
9 Sep 2025Agreement to buy ~27% of Aptamer Sciences for KRW 4.4 bn plus rights-issue participation; Aptamer also issued a KRW 10 bn CBEntry into bio/CRO
30 Sep 2025Third-party allotment of 9.12 m pre-reduction shares to Vision2 at KRW 548About KRW 5 bn of new equity; a new 15% holder
14 Oct 2025Vision2 filed its 15.01% holding report; share price about KRW 571 (pre-reduction)Ownership disclosure
24 Oct 2025First Aptamer rights-issue tranche (KRW 10 bn) scheduled paymentCapital injection into Aptamer
27 Oct 2025Aptamer share purchase closed; Alticast holds 7,079,827 shares (17.59%)Control established
28 Nov 2025Second Aptamer rights-issue tranche scheduled paymentFurther dilution of Aptamer minorities
Dec 2025 / Jan 2026Beno T&R faced a tax-audit report and a "trading concentration" investment-caution designation (TheVC headlines; dates not specified)Parent-level governance risk
11 Mar 2026Board announced the 5-to-1 capital reduction. FY2025 revenue KRW 53.1 bn (+835%), operating profit KRW 3.2 bn. Pre-reduction share price KRW 472.Balance-sheet clean-up; turnaround narrative
11 Mar 2026CEO Chung said the share-price fall reflected market misunderstanding of the reductionManagement messaging
Mar 2026AGM approved the capital reductionCorporate action approved
25 Mar 2026Aptamer agreed to acquire Choolip Inc. (USD 11.4 m / KRW 17.2 bn)US pet-food entry
6 Apr 2026Company release on financial improvement and portfolio; target to become a quality company in two to three yearsInvestor relations
8 Apr 2026Reverse split effective (0.2 ratio)Share count about 12–14 m
22 Jun 2026Shares fell 8.4% to KRW 1,259 in one sessionVolatility
1 Jul 2026KOSDAQ market-cap delisting threshold raised to KRW 20 bn, rising to KRW 30 bn in Jan 2027Alticast trades near or below the threshold
3 Jul 2026Beno T&R controlling stake sale to Acro New Technology Fund No. 241 agreed; KRW 10 bn placementIndirect change of control pending
6 Jul 2026Beno T&R shares hit the upper limit on the newsParent re-rating (temporary)
Jul–Aug 2026Beno T&R traded below KRW 1,000 for 25 consecutive sessions and narrowly avoided administrative-issue designationParent listing risk
14 Aug 2026Q2 2026 financial data updated (S&P): TTM revenue KRW 74.3 bn, TTM operating loss KRW 0.29 bn, TTM net loss KRW 5.4 bnProfitability slipped
27 Aug 2026H1 2026 report date (S&P)Disclosure
Aug 2026Beno T&R balance payment postponed to 14 Sep 2026Deal-completion risk
9 Sep 2026Share price KRW 1,506; 52-week change –54.8% (S&P)Sustained derating
8 Oct 2026Market cap KRW 19.24 bn (S&P), below the KRW 20 bn KOSDAQ thresholdListing-maintenance watch
14 Oct 2026Close KRW 1,401Latest price

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

3 charts
Income Statement: Revenue & Gross Profit: Revenue rose from KRW 36,254 Mn in FY2021 to KRW 53,166 Mn in FY2025.
Alticast Corporation — Income Statement: Revenue & Gross Profit
Series (KRW Mn)FY2021FY2022FY2023FY2024FY2025
Revenue36,2547,2455,6585,68153,166
Cost of revenue1,96215943,26039,858
Gross profit34,2927,0865,6542,42013,308

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. S&P Global Market Intelligence via StockAnalysis.com: Alticast overview, income statement, balance sheet, cash flow, ratios, statistics and company profile (accessed Oct 2026) (stockanalysis.com)
  2. Eulerpool, Alticast (KR7085810000) (eulerpool.com)
  3. Asia Economy, 11 Mar 2026, "Alticast 5-to-1 capital reduction": (English: asiae.co.kr · view.asiae.co.kr
  4. Asia Economy, 6 Apr 2026, "Alticast financial improvement and earnings rebound" (view.asiae.co.kr)
  5. Dealsite, 9 Sep 2025, "Aptamer Sciences sells control to Alticast" (dealsite.co.kr)
  6. Digital Today, Oct 2025, Vision2 holding report (digitaltoday.co.kr)
  7. Digital Today, Oct 2025, Alticast holding in Aptamer Sciences (digitaltoday.co.kr)
  8. Asia Economy, 19 Dec 2024, "Beno T&R acquires Alticast" (asiae.co.kr)
  9. Asia Economy, 13 Jan 2025, "Beno T&R Alticast acquisition on track" (asiae.co.kr)
  10. Edaily, 6 Jul 2026, Beno T&R change of largest shareholder (en.edaily.co.kr)
  11. Chosun Biz via Daum, 7 Jul 2026, Beno T&R control sale (v.daum.net)
  12. Dealsite, 20 Aug 2026 and 31 Aug 2026, Beno T&R · dealsite.co.kr
  13. IB Tomato, Jul 2025, Beno T&R funding (newstomato.com)
  14. Sidae, Jun 2023, Beno Holdings / Lamicus (sidae.com)
  15. Sidae, Aug 2026, Humax / KOSDAQ market-cap thresholds (sidae.com)
  16. Money Today, 26 Mar 2026, Aptamer Sciences / Choolip (mt.co.kr)
  17. Money Today, Jul 2025, Aptamer Sciences (mt.co.kr)
  18. eToday, Jun 2024, Aptamer / ISS merger (etoday.co.kr)
  19. Biospectator, Aptamer Sciences background · biospectator.com
  20. IRGO, Aptamer Sciences IR room (m.irgo.co.kr)
  21. BizWatch, 3 Dec 2021, KT completes Altimedia acquisition (news.bizwatch.co.kr)
  22. Aju Business Daily, 3 Dec 2021 (ajunews.com)
  23. Newstomato, Dec 2021 (newstomato.com)
  24. Aju Business Daily, 6 Apr 2021, Alticast EV-charging theme / FY2020 results (ajunews.com)
  25. Hankyung, 22 Oct 2013, Alticast IPO filing (hankyung.com)
  26. eToday, 18 Nov 2013, Alticast IPO briefing (etoday.co.kr)
  27. eToday, Aug 2015, Humax Holdings / Geonin Investment merger (etoday.co.kr)
  28. TaxWatch, Feb 2020, Humax group structure (taxwatch.co.kr)
  29. TheVC, Alticast (thevc.kr)
  30. TheVC, KT Altimedia (thevc.kr)
  31. TheVC, J&J Investment (thevc.kr)
  32. TheVC, Altimobility (thevc.kr)
  33. Jasoseol, Alticast company data (jasoseol.com)
  34. MyDailyByte, Alticast (mydailybyte.com)
  35. Wanted, Castis (wanted.co.kr)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.